Portage Biotech Files 6-K, Incorporates S-8 Registration
Ticker: ATON · Form: 6-K · Filed: Sep 4, 2024 · CIK: 1095435
| Field | Detail |
|---|---|
| Company | Portage Biotech INC. (ATON) |
| Form Type | 6-K |
| Filed Date | Sep 4, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $1.00 m, $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, registration-statement
TL;DR
Portage Biotech filed a 6-K, confirming 20-F reporting and incorporating its S-8 registration statement.
AI Summary
Portage Biotech Inc. filed a Form 6-K on September 4, 2024, to report for the month of September 2024. The filing indicates that the company is a foreign private issuer and will file annual reports under Form 20-F. The report also incorporates by reference its registration statement on Form S-8 (File No. 333-275842).
Why It Matters
This filing provides routine updates and confirms the company's reporting status, which is important for investors tracking its regulatory compliance and ongoing filings.
Risk Assessment
Risk Level: low — This is a routine filing that does not contain new material financial information or significant operational updates.
Key Players & Entities
- Portage Biotech Inc. (company) — Filer of the Form 6-K
- 333-275842 (dollar_amount) — File number for the Form S-8 registration statement
- 20-F (company) — Annual report form type
- 6-K (company) — Form type filed
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is filed by Portage Biotech Inc. to report for the month of September 2024 and to incorporate by reference its registration statement on Form S-8 (File No. 333-275842).
What is Portage Biotech Inc.'s reporting status?
Portage Biotech Inc. is a foreign private issuer and indicates it will file annual reports under cover of Form 20-F.
What is the file number for the incorporated registration statement?
The registration statement incorporated by reference is on Form S-8 and has the file number 333-275842.
What is the principal executive office address of Portage Biotech Inc.?
The principal executive office is located at Clarence Thomas Building, P.O. Box 4649, Road Town, Tortola, British Virgin Islands, VG1110.
When was the company formerly known as Bontan Corp Inc.?
The company was formerly known as Bontan Corp Inc. with a date of name change on April 21, 2003.
Filing Stats: 321 words · 1 min read · ~1 pages · Grade level 11.4 · Accepted 2024-09-03 17:59:48
Key Financial Figures
- $1.00 m — Company was not in compliance with the $1.00 minimum bid price requirement for continu
- $1.00 — having a closing bid price of at least $1.00 per share for the 11 consecutive busine
Filing Documents
- f6k_090324.htm (6-K) — 8KB
- 0001171843-24-005042.txt ( ) — 9KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: September 3, 2024 PORTAGE BIOTECH INC. By: /s/ Allan Shaw Allan Shaw Chief Financial Officer